Kalytera to Hold Annual and Special Meeting on July 29, 2019
05 juil. 2019 17h07 HE
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, July 05, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) announced today that it is holding...
Kalytera Announces Grant of Stock Options to Directors
21 juin 2019 17h47 HE
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, June 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
Kalytera Therapeutics, Inc. Announces Second Closing of Public Offering
14 mai 2019 10h33 HE
|
Kalytera Therapeutics, Inc.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANCISCO...
Kalytera Reports 2018 Financial Results
01 mai 2019 16h10 HE
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, May 01, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial results...
Kalytera Therapeutics, Inc. Announces Closing of Public Offering
26 avr. 2019 10h16 HE
|
Kalytera Therapeutics, Inc.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANSISCO...
Kalytera Therapeutics Announces Filing of Short Form Prospectus
17 avr. 2019 13h02 HE
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, April 17, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”, or...
Kalytera Therapeutics Announces Short Form Prospectus Offering of Units
03 avr. 2019 08h01 HE
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, April 03, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”,...
Kalytera Announces Closing of Private Placement of Convertible Debenture Units
07 mars 2019 18h54 HE
|
Kalytera Therapeutics, Inc.
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, March 07, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY...
Kalytera Announces Private Placement of Convertible Debenture Units
05 mars 2019 08h54 HE
|
Kalytera Therapeutics, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES SAN FRANCISCO and TEL AVIV, Israel, March 05, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY...
Kalytera Announces Share Issuance for January Invoices under Payments Agreements with Salzman Group
26 févr. 2019 09h26 HE
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...